On ECHEMI
Home > Drugs > Nonalcoholic fatty liver disease
Nonalcoholic fatty liver disease
Nonalcoholic fatty liver disease (NAFLD) refers to a clinical pathological syndrome characterized by diffuse macrovesicular steatosis of hepatocytes, excluding alcohol and other clear liver-damaging factors. It includes simple fatty liver and its evolved steatohepatitis (NASH) and cirrhosis.
Related Drugs
Lecithin tablets
Indication: Used as an auxiliary treatment for diseases such as fatty liver and atherosclerosis.
Manufacturer:

Jiuquan Dadeli Pharmaceutical Co., Ltd.

Related Ingredients
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.